Collin Kim
Patrimonio netto: 19 929 $ in data 31/07/2026
Patrimonio netto: 19 929 $ in data 31/07/2026
Sang Goo Kim is currently Director at Biocure Technology, Inc. since 2015 and Vice President at Columbia Capital, Inc. since 2008.
Former positions include Independent Director at Gravis Energy Corp.
and Independent Director at First Atlantic Nickel & Cobalt Corp.
from 2015 to 2020.
Education includes an undergraduate degree from Korea University, conferred in 1990.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/07/2025 | 1.992.877 ( 9,86% ) | 19 929 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BIOCURE TECHNOLOGY INC. | Direttore/Membro del Consiglio | 28/08/2015 |
Columbia Capital, Inc.
Columbia Capital, Inc. Investment ManagersFinance Provides investment advisory services | Corporate Officer/Principal | 01/01/2008 |
| Società | Posizione | Fine |
|---|---|---|
Gravis Energy Corp.
Gravis Energy Corp. Other Metals/MineralsNon-Energy Minerals Explores and develops uranium, natural resources | Direttore/Membro del Consiglio | - |
| FIRST ATLANTIC NICKEL & COBALT CORP. | Amministratore Delegato | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
First Atlantic Nickel Corp.
First Atlantic Nickel Corp. Other Metals/MineralsNon-Energy Minerals Engages in the acquisition, evaluation, exploration, and development of oil, gas, and mineral resources | Non-Energy Minerals |
Korea University
Korea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gravis Energy Corp.
Gravis Energy Corp. Other Metals/MineralsNon-Energy Minerals Explores and develops uranium, natural resources | Non-Energy Minerals |
Columbia Capital, Inc.
Columbia Capital, Inc. Investment ManagersFinance Provides investment advisory services | Finance |
Biocure Technology, Inc.
Biocure Technology, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale